Bone tissue engineering induced composite scaffolds for repair of bone defects

doi:10.3969/j.issn.2095-4344.2015.03.003

Abstract

Abstract:

BACKGROUND: In the early experiments, icariin chitosan/collagen/polycaprolactone/hydroxyapatite (CS/Col/PCL/HA) composite scaffold has good physical and chemical properties.

OBJECTIVE: To study the effect of CS/Col/PCL/HA composite scaffolds to repair bone defects of rabbit tibia platform.

METHODS: The outer of Col/PCL/HA composite scaffolds were prepared by electrospinning, and the core containing chitosan microspheres/collagen was made by vacuum freeze-drying process. Then the core was implanted into the outer to construct the drug-loading composite scaffold by genipin crosslinking. The microspheres carrying icariin chitosan were immersed into PBS to observe the slow-release effect. The composite scaffold was used to culture rat bone marrow mesenchymal stem cells for 7 days to observe cell adhesion. Fifteen chinchilla rabbits were taken to make the model of left tibia bone defect, and then randomly divided into three groups: CS/Col/PCL/HA composite scaffold group, Col/PCL/HA composite scaffold group, and blank control group with no materials. X-ray observation, gross observation, and histopathological observation were performed at 4, 12, 24 weeks after the surgery.

RESULTS AND CONCLUSION: The drug-loading composite scaffold had a porous structure that was conducive to cell adhesion and proliferation. Chitosan microspheres kept a 19% drug release within 72 hours in vitro. Twenty-four weeks after surgery, CS/Col/PCL/HA composite scaffolds were completely covered by the newly formed bone tissue, and the scaffold surfaces were smooth and had hardness close to normal bone tissue; hematoxylin-eosin staining showed bone trabecula, bone cells and osteoblasts, but X-ray images showed the bone mineral density in the defect area was slightly lower than that of the normal bone tissue. Col/PCL/HA composite scaffolds were wrapped up by fibrous tissue, and hematoxylin-eosin staining showed bone trabecula, bone marrow cells and dense fibrous tissue. In the blank control group, the hardness of defect areas was significantly lower than that of the normal bone and hematoxylin-eosin staining showed a large number of bone marrow cells and bone trabeculae. The experimental results showed that CS/Col/PCL/HA composite scaffold could repair rabbit bone defects effectively.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

全文链接：

Key words: Collagen, Chitosan, Hydroxyapatites

CLC Number:

R318

Tang Jun-jie, Li Wen-jie, Li Gen, Wang Jiu-na, Zhao Ling, Qin Wen, Zhao Hong-bin. Bone tissue engineering induced composite scaffolds for repair of bone defects[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(3): 340-346.

Figures/Tables 6

References

[1]袁冰,韦卓.骨缺损修复的研究进展[J].生物骨科材料与临床研究, 2014,11(3):38-41.
[2]方志伟,李舒,樊征夫,等.异种骨和人工骨修复骨肿瘤性骨缺损[J].中国组织工程研究,2014,18(16):2468-2473.
[3]王小红,马建彪,王亦农,等.骨修复材料的研究进展[J].生物医学学杂志,2001,18(4):647-652.
[4]孙文晓,张海巷,韦卓,等.骨修复材料的研究应用现状与展望[J].生物骨科材料与临床研究,2009,6(3):35-40.
[5]刘博,贾全章.复合材料修复骨缺损的研究进展[J].吉林医学, 2013, 34(10):1919-1921.
[6]Sagar N,Pandey AK,Gurbani D,et al.In-Vivo Efficacy of Compliant 3D Nano-Composite in Critical-Size Bone DefectRepair: a Six Month Preclinical Study in Rabbit.PLoS One.2013;8(10):e77578.
[7]杨毅,毕鑫,李多玉,等.人工骨材料修复骨缺损:多种复合后的生物学与力学特征[J].中国组织工程研究,2014,18(16): 2582-2587.
[8]肖建德,熊建义,欧阳侃,等.纳米陶瓷人工骨修复骨缺损的实验研究[J].中华创伤骨科杂志,2006,8(11):1048-1052.
[9]王浩,张里程,石涛,等.胶原-羟基磷灰石-硫酸软骨素-骨形态发生蛋白骨修复材料的性质评估[J].北京大学学报:医学版,2011, 43(5):730-734.
[10]邢自宝,刘永刚,苏佳灿.骨缺损修复研究进展[J].临床医学工程, 2010,17(2):145-147.
[11]张建新,张展望,常峰.组织工程化人工骨修复骨缺损的实验研究[J].中国矫形外科杂志,2009,17(16):1258-1261.
[12]刘艳辉,谢利娜.淫羊藿在骨膜附加活性材料nHAC/PLA修复颌骨缺损中的影响[J].广州中医药大学学报,2014,31(5):791-794.
[13]赵红霞.载药壳聚糖/羟基磷灰石复合支架在骨组织工程中的研究进展[J].功能材料,2014,13(45):1306-1312.
[14]吴涛,徐俊昌,南开辉,等.淫羊藿苷促进羊骨髓间充质干细胞的增殖和成骨分化[J].中国组织工程研究与临床康复,2009,13(19): 3725-3729.
[15]贾亮亮,袁丁,王洪武,等.淫羊藿苷药理作用的研究进展[J].现代生物医学进展,2010,10(20):3976-3979.
[16]于波,杨久山,刘岩,等.淫羊藿苷对人成骨细胞的作用[J].中医正骨,2006,18(6):17-19.
[17]李恩中.组织工程研究的新策略-组织诱导性生物材料[J].生物医学工程学杂志,2009, 26(3):461-464.
[18]Rajangam T,An SS.Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.Int J Nanomedicine.2013;8:3641-3662.
[19]朱美忠,李晓斌,陈滔.纳米羟基磷灰石/聚酰胺66复合生物活性人工骨在肢体骨缺损应用87例[J].创伤外科杂志,2014,16(1): 29-31.
[20]王大平,熊建义,朱伟民,等.纳米羟基磷灰石人工骨在骨缺损修复中的临床应用研究[J].中国临床解剖学杂志,2014,32(2): 670-673.
[21]Mok SK,Chen WF,Lai WP,et al.Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions inUMR 106 cells. Br J Pharmacol.2010;159(4):939-949.
[22]Li XF, Xu H, Zhao YJ,et al.Icariin Augments Bone Formation and Reverses the Phen-otypes of Osteoprotegerin-Deficient Mice through the Activation of Wnt/β-Catenin-BMP Signaling. Evid Based Complement Alternat Med. 2013;2013:652317.
[23]殷晓雪,陈仲强,党耕町,等.淫羊藿苷对人成骨细胞增殖与分化的影响[J].中国中药杂志,2005, 30(4):289-291.
[24]郭海玲,赵咏芳,王翔,等.淫羊藿苷对人成骨细胞增殖及OPG蛋白表达的实验研究[J].中国骨伤,2011,24(7):585-588.
[25]Xue L,Jiao L,Wang Y,et al.Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption. Evid Based Complement Alternat Med. 2012;2012:490843.